Nisa Investment Advisors, LLC Biomarin Pharmaceutical Inc Transaction History

Nisa Investment Advisors, LLC

  • $16.7 Billion
  • Q3 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 6,185 shares of BMRN stock, worth $392,252. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,185
Previous 11,760 47.41%
Holding current value
$392,252
Previous $968,000 55.17%
% of portfolio
0.0%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
SELL
$69.02 - $93.84 $384,786 - $523,158
-5,575 Reduced 47.41%
6,185 $434,000
Q2 2024

Jul 19, 2024
SELL
$74.43 - $92.22 $53,961 - $66,859
-725 Reduced 5.81%
11,760 $968,000
Q1 2024

May 01, 2024
SELL
$83.81 - $99.0 $44,419 - $52,470
-530 Reduced 4.07%
12,485 $1.09 Million
Q4 2023

Jan 25, 2024
SELL
$76.22 - $98.51 $30,488 - $39,404
-400 Reduced 2.98%
13,015 $1.25 Million
Q3 2023

Nov 02, 2023
SELL
$85.07 - $94.48 $187,153 - $207,856
-2,200 Reduced 14.09%
13,415 $1.19 Million
Q1 2023

May 02, 2023
SELL
$87.74 - $117.27 $328,674 - $439,293
-3,746 Reduced 19.35%
15,615 $1.52 Million
Q4 2022

Feb 02, 2023
SELL
$80.93 - $108.63 $309,961 - $416,052
-3,830 Reduced 16.52%
19,361 $2 Million
Q3 2022

Nov 07, 2022
BUY
$82.16 - $96.94 $101,303 - $119,527
1,233 Added 5.62%
23,191 $1.97 Million
Q2 2022

Aug 03, 2022
SELL
$71.48 - $86.85 $262,974 - $319,521
-3,679 Reduced 14.35%
21,958 $1.82 Million
Q1 2022

Apr 29, 2022
BUY
$74.28 - $92.69 $703,060 - $877,310
9,465 Added 58.53%
25,637 $1.98 Million
Q4 2021

Feb 03, 2022
SELL
$71.72 - $91.47 $325,967 - $415,731
-4,545 Reduced 21.94%
16,172 $1.43 Million
Q3 2021

Oct 18, 2021
SELL
$74.77 - $85.47 $15,926 - $18,205
-213 Reduced 1.02%
20,717 $1.6 Million
Q2 2021

Aug 06, 2021
BUY
$75.51 - $84.79 $22,653 - $25,437
300 Added 1.45%
20,930 $1.75 Million
Q1 2021

Apr 26, 2021
BUY
$74.73 - $90.69 $22,419 - $27,207
300 Added 1.48%
20,630 $1.56 Million
Q4 2020

Jan 25, 2021
SELL
$72.61 - $90.2 $271,488 - $337,257
-3,739 Reduced 15.53%
20,330 $1.78 Million
Q3 2020

Oct 20, 2020
SELL
$71.87 - $131.03 $1.08 Million - $1.96 Million
-14,971 Reduced 38.35%
24,069 $1.83 Million
Q2 2020

Jul 27, 2020
BUY
$79.55 - $124.22 $439,991 - $687,060
5,531 Added 16.51%
39,040 $4.82 Million
Q1 2020

Apr 17, 2020
BUY
$71.37 - $96.85 $342,576 - $464,880
4,800 Added 16.72%
33,509 $2.83 Million
Q4 2019

Jan 17, 2020
BUY
$64.27 - $86.37 $159,003 - $213,679
2,474 Added 9.43%
28,709 $2.43 Million
Q3 2019

Oct 17, 2019
SELL
$67.4 - $85.11 $274,183 - $346,227
-4,068 Reduced 13.42%
26,235 $1.77 Million
Q2 2019

Jul 12, 2019
SELL
$80.35 - $93.9 $343,094 - $400,953
-4,270 Reduced 12.35%
30,303 $2.6 Million
Q1 2019

Apr 17, 2019
SELL
$84.2 - $98.62 $38,647 - $45,266
-459 Reduced 1.31%
34,573 $3.07 Million
Q4 2018

Jan 17, 2019
SELL
$80.14 - $106.07 $88,154 - $116,676
-1,100 Reduced 3.04%
35,032 $2.98 Million
Q3 2018

Oct 16, 2018
BUY
$93.92 - $105.72 $1.65 Million - $1.86 Million
17,612 Added 95.1%
36,132 $3.5 Million
Q2 2018

Jul 19, 2018
BUY
$76.01 - $99.03 $532,070 - $693,210
7,000 Added 60.76%
18,520 $1.75 Million
Q1 2018

Apr 10, 2018
BUY
$77.67 - $92.63 $58,252 - $69,472
750 Added 6.96%
11,520 $934,000
Q4 2017

Jan 12, 2018
SELL
$80.76 - $95.13 $4,038 - $4,756
-50 Reduced 0.46%
10,770 $960,000
Q3 2017

Oct 13, 2017
BUY
$80.6 - $94.95 $872,091 - $1.03 Million
10,820
10,820 $1.01 Million

Others Institutions Holding BMRN

# of Institutions
635
Shares Held
178M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email